Skip to content
HowShorted

Novavax, Inc. short interest in 2019

In 2019, Novavax, Inc.'s disclosed short interest ran from 16.00% of shares outstanding on 15 Jan 2019 to 20.41% on 31 Dec 2019, a change of +4.41 percentage points. The year's high was 21.78% on 15 Apr 2019 and its low 16.00% on 15 Jan 2019, averaging 19.52% across 19 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 11.18 days on 31 Jul 2019. Full history: Novavax, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Novavax, Inc. in 2019

2019 in figures

Start of year
16.00% (15 Jan 2019)
End of year
20.41% (31 Dec 2019)
Change
+4.41 pp
High
21.78% (15 Apr 2019)
Low
16.00% (15 Jan 2019)
Average
19.52%
Highest days to cover
11.18 (31 Jul 2019)
SEC filings marked
8

Every report in 2019

Novavax, Inc. short interest in 2019
SettlementShort interestDays to coverFilings since previous
15 Jan 201916.00%5.38
31 Jan 201916.66%7.72
15 Feb 201918.94%9.84
28 Feb 201920.68%3.91
15 Mar 201921.41%3.00
29 Mar 201920.84%4.1710-K filed, results (8-K)
15 Apr 201921.78%7.49
30 Apr 201918.76%8.31
31 Jul 201921.73%11.1810-Q filed, results (8-K)
15 Aug 201921.34%3.8410-Q filed, results (8-K)
30 Aug 201920.13%3.43
13 Sep 201920.46%7.12
30 Sep 201920.54%6.24
15 Oct 201919.00%9.73
31 Oct 201917.63%9.22
15 Nov 201917.66%7.1110-Q filed, results (8-K)
29 Nov 201918.23%4.43
13 Dec 201918.66%3.34
31 Dec 201920.41%6.47

See also: Novavax, Inc.'s full history · most shorted US stocks of 2019 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.